Eukaryotic Pathogens Innovation Center (EPIC)
Clemson scientist receives $1.77M NIH grant to continue research on deadly parasites
Clemson undergraduates invest in the future by teaching science to middle-schoolers despite pandemic
EPIC scientist receives $369K grant to study parasite that causes African sleeping sickness
Clemson researcher’s mini-review featured in ‘Early-Career Scientist’ series
The Eukaryotic Pathogens Innovation Center (EPIC), founded in January 2013, is an interdisciplinary research cooperative at Clemson University. It stands at the forefront of biomedical research on eukaryotic pathogens, which are the causative agents of some of the most devastating and intractable diseases of humans including malaria, amoebic dysentery, sleeping sickness, Chagas disease, and fungal meningitis. Globalization has resulted in an increase in such infections in the US and many eukaryotic pathogens are also classified as bioterrorism agents and/or neglected tropical diseases (NTDs). The global importance of these pathogens is what motivates our faculty members, who have established a lengthy track record of major contributions in this area of research.
No Feed Results